HER2-positive breast cancer treatment and survival rate

in #breastcancer • 2 years ago

Human epidermal growth factor receptor 2 (HER2) is an overexpressed protein in certain types of breast cancer, including HER2-positive breast cancer. Surgery, chemotherapy, radiation therapy, and targeted therapy are frequently used to treat HER2-positive breast cancer. Trastuzumab (Herclon 440mg Injection), a medication that precisely targets the HER2 protein, is the primary targeted therapy for HER2-positive breast cancer. Pertuzumab (Perjeta) and ado-trastuzumab emtansine (Kadcyla) are other possible targeted therapeutics. HER2-positive breast cancer treatment and survival rate

#her2positive #breast #cancer
2 years ago in #breastcancer by
$0.00
    Reply 0

    Coin Marketplace

    STEEM 0.17
    TRX 0.24
    JST 0.034
    BTC 96677.33
    ETH 2767.67
    SBD 0.65